| Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 R Lozano, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, ... The lancet 380 (9859), 2095-2128, 2012 | 18152 | 2012 |
| Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 M Ng, T Fleming, M Robinson, B Thomson, N Graetz, C Margono, ... The lancet 384 (9945), 766-781, 2014 | 15433 | 2014 |
| Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 CJL Murray, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, ... The lancet 380 (9859), 2197-2223, 2012 | 11375 | 2012 |
| Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 T Vos, AD Flaxman, M Naghavi, R Lozano, C Michaud, M Ezzati, ... The lancet 380 (9859), 2163-2196, 2012 | 10321 | 2012 |
| Effects of intensive glucose lowering in type 2 diabetes HC Gerstein, ME Miller, RP Byington, DC Goff, JT Bigger, JB Buse, ... N Engl J Med 358 (24), 2008 | 9860* | 2008 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … MH Forouzanfar, A Afshin, LT Alexander, HR Anderson, ZA Bhutta, ... The lancet 388 (10053), 1659-1724, 2016 | 8032 | 2016 |
| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7130 | 2015 |
| Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin Diabetes Prevention Program Research Group New England journal of medicine 346 (6), 393-403, 2002 | 5870 | 2002 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 5551 | 2015 |
| Effects of intensive blood-pressure control in type 2 diabetes mellitus WT Friedewald, JB Buse, JT Bigger, HC Gerstein, F Ismail-Beigi N Engl J Med 362, 1575-85, 2010 | 4342* | 2010 |
| Effects of combination lipid therapy in type 2 diabetes mellitus HN Ginsberg, MB Elam, LC Lovato, JR Crouse 3rd, LA Leiter, P Linz, ... The New England journal of medicine 362 (17), 1563, 2010 | 3462* | 2010 |
| The state of US health, 1990-2010: burden of diseases, injuries, and risk factors CJL Murray, J Abraham, MK Ali, M Alvarado, C Atkinson, LM Baddour, ... Jama 310 (6), 591-606, 2013 | 3241 | 2013 |
| Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis SR Flaxman, RRA Bourne, S Resnikoff, P Ackland, T Braithwaite, ... The Lancet Global Health 5 (12), e1221-e1234, 2017 | 3117 | 2017 |
| Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes Look AHEAD Research Group New England journal of medicine 369 (2), 145-154, 2013 | 3060 | 2013 |
| Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials SL Norris, MM Engelgau, KM Venkat Narayan Diabetes care 24 (3), 561-587, 2001 | 2835 | 2001 |
| Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis RRA Bourne, SR Flaxman, T Braithwaite, MV Cicinelli, A Das, JB Jonas, ... The Lancet Global Health 5 (9), e888-e897, 2017 | 2530 | 2017 |
| Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying … CJL Murray, RM Barber, KJ Foreman, AA Ozgoren, F Abd-Allah, SF Abera, ... The Lancet 386 (10009), 2145-2191, 2015 | 2373* | 2015 |
| Lifetime risk for diabetes mellitus in the United States KMV Narayan, JP Boyle, TJ Thompson, SW Sorensen, DF Williamson Jama 290 (14), 1884-1890, 2003 | 2138 | 2003 |
| Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 … B Zhou, RM Carrillo-Larco, G Danaei, LM Riley, CJ Paciorek, GA Stevens, ... The Lancet 398 (10304), 957-980, 2021 | 2094 | 2021 |
| Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial F Ismail-Beigi, T Craven, MA Banerji, J Basile, J Calles, RM Cohen, ... The Lancet 376 (9739), 419-430, 2010 | 1781 | 2010 |
